CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
Subscribe
CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
SEARCH
SEARCH
advanced search
INTERVIEW
INTERVIEW
ERIK HAEFFLER, RECIPHARM
In this interview, Erik Haeffler discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety and efficacy standard for achieving its main objective of promoting patient health and wellbeing.
INTERVIEW
ANDREI YOSEF, CEO, SORREL MEDICAL
In this exclusive interview, Andrei Yosef discusses Sorrel’s differentiated electro-mechanical, connected wearable injection platform, and two exciting recent milestones for the company, the opening of a state-of-the-art manufacturing facility and the signing of a significant partnership with a large pharma company.
INTERVIEW
Aaron Mann
INTERVIEW WITH AARON MANN, CHIEF EXECUTIVE OFFICER, KINDEVA
In this exclusive interview with ONdrugDelivery, Aaron Mann discusses how Kindeva is positioned to move forward as a major CDMO specialising in inhalation and transdermal dosage forms, having been formed from 3M’s drug delivery in May 2020. We also cover the impact of Covid-19, environmental sustainability, and current challenges faced by the pharmaceutical industry.
ROUNDTABLE
Dr Jeremy Drummond
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.
INTERVIEW
Maria Flynn
Adare Pharmaceuticals
INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS
Adare Pharma's Maria Flynn talks with ONdrugDelivery about trends in the oral drug development and delivery space, completing the Orbis Biosciences acquisition during a global pandemic, and how the excellent technology portfolio and strategic fit between Orbis and Adare form part of the combined organisation’s unique story.
INTERVIEW
Milena Batalla
Panarum
INTERVIEW WITH MILENA BATALLA, PHD, PANARUM
Dr Batalla introduces the company and describes its Proteoral
®
technology for the oral delivery of proteins to the bloodstream, therapeutic applications, and products to date. Panarum is an Argentine company and this interview is presented here in Spanish and English, an exciting first for ONdrugDelivery!
INTERVIEW
Sai Shankar
Aptar Pharma
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
INTERVIEW
Steven Kaufman
Stevanato Group
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.
INTERVIEW
Dr Gautam N Shetty
Congruence Medical Solutions
INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE
In this interview, Dr Sri Mudumba, Santen, and Dr Gautam N Shetty, Congruence Medical Solutions, share insights from their experience of working together in developing the MDS for ophthalmic injections.
INTERVIEW
Cecile Halte
BD (Becton Dickinson & Company)
Cecile Halte, BD
In this interview, Cécile Halté, Senior Program Manager, Acute Care Segment, for BD Medical – Pharmaceutical Systems. discusses validation studies of the BD Sterifill Advance™ plastic prefilled syringe, which is intended for use in the hospital setting by healthcare professionals either for manual bolus injections, or with infusion pumps.
INTERVIEW
Bob Tilling
Bob Tilling, Kallik
In this interview, Bob Tilling, Business Development Manager at Kallik, shares his insights on best practice for factory labelling.
CONNECTIVITY
Eric Dessertenne
Biocorp
COMPLETING ITS TRANSITION FROM GENESIS TO MATURITY, BIOCORP OPENS NEW HORIZONS
As Biocorp prepares for the market launch of its connected injector pen add-on, Mallya, Eric Dessertenne and Arnaud Guillet share insights about key steps in the company’s development. The article discusses the many partnership Biocorp has entered in to, and includes a mini-interview with Sergio Monti, Plant Manager for one such partner, V.A.R.I.
INTERVIEW
Dr Mircea Despa
BD (Becton Dickinson & Company)
MIRCEA DESPA & DOUG McCLURE, BD
In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.
INTERVIEW
Guillaume Brouet
Aptar Pharma
GUILLAUME BROUET, APTAR PHARMA
Guillaume Brouet talks with ONdrugDelivery Magazine about how Aptar Pharma uses its device development expertise and infrastructure to provide its pharmaceutical company customers a comprehensive services offering around device development, global regulatory approval and commercialisation.
INTERVIEW
Paul Allsop
Bespak by Recipharm
PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP
Consort Medical's Paul Allsop, Miles Kottman, Hannah Priestly and Jon Reed talk with ONdrugDelivery Magazine about the company’s integrated formulation and device offering, and focus on its simple, low-cost, single unit-dose, spring powered nasal device, Unidose Xtra.
INTERVIEW
Sagar Bejalwar
BD (Becton Dickinson & Company)
SAGAR BEJALWAR, BD MEDICAL – PHARMACEUTICAL SYSTEMS
Sagar Bejalwar discusses the product and clinician needs in delivering hyaluronic acid for cosmetic applications.
INTERVIEW
Dr Alice Maden
BD (Becton Dickinson & Company)
ALICE MADEN & LIONEL MARITAN, BD MEDICAL – PHARMACEUTICAL SYSTEMS
Alice Maden and Lionel Maritan discuss with detailed expert knowledge the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems.
INTERVIEW
Dr Norbert Haberland
Datwlyer
NORBERT HABERLAND, DATWYLER
Norbert Haberland discusses Datwyler’s interests in the field of wearable technology in the healthcare sector.
INTERVIEW
Dr John Patton
Dance Biopharm
BILL WELCH, PHILLIPS-MEDISIZE & JOHN PATTON, DANCE BIOPHARM
In this exclusive interview with ONdrugDelivery Magazine, Bill Welch and John Patton discuss inhaled insulin, connectivity and their two companies’ close partnership
INTERVIEW
Tom Van Ginneken
SCHOTT
TOM VAN GINNEKEN, SCHOTT
Tom Van Ginneken discusses the advantages of polymers as a material for primary pharmaceutical packaging and how the company supports pharma manufacturers with engineering capabilities for individualised containers and rapid prototyping.
INTERVIEW
Torsten Maschke
TORSTEN MASCHKE, DATWYLER SEATLING SOLUTIONS
Torsten Maschke discusses the industrialisation of drug delivery, from the perspective of an industrialisation specialist partner for the pharmaceutical industry, looking at the trends in the field today and the advantages of the modern paradigm of partnering.
INTERVIEW
Eric Dessertenne
Biocorp
ERIC DESSERTENNE, BIOCORP
Eric Dessertenne talks in-depth with ONdrugDelivery Magazine about the ways connectivity is developing within the pharmaceutical industry, its likely future course and how Biocorp is positioned.
INTERVIEW
Dr Sundeep Kankanala
BD (Becton Dickinson & Company)
SUNDEEP KANKANALA, BD
Sundeep Kankanala discusses the challenges faced by today’s biopharmaceutical industry, in particular those posed by the need for large volumes and the issues caused by the use of silicone in prefilled syringes.
INTERVIEW
John Merhige
Credence MedSystems
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.
INTERVIEW
Fanny Sellier
Nemera
FANNY SELLIER, NEMERA
Talking here with ONDrugDelivery Magazine, Ms Sellier discusses Nemera’s multidose eyedropper system Novelia® for preservative-free formulations. She explains how this platform has been developed to improve patients’ lives.
INTERVIEW
Neil Williams
NEIL WILLIAMS, MEDICOM INNOVATION PARTNER
In this interview with ONdrugDelivery Magazine, Williams discusses the crucial role connectivity is taking in the drug delivery device industry.
INTERVIEW
Torsten Maschke
TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS
Torsten Maschke has been Chief Executive of the Sealing Solutions division of Datwyler and a member of the group’s Executive Board since October 2016. Before joining Datwyler Group, he was responsible for the worldwide distribution of sealing and damping solutions for the automotive industry at Freudenberg Group (Weinheim, Germany).
INTERVIEW
Steven Kaufman
Bespak by Recipharm
STEVEN R KAUFMAN, BESPAK
Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.
INTERVIEW
Derek Brandt
Sensile Medical
GETTING TO KNOW SENSILE MEDICAL
Chief Executive Officer Derek Brandt and three of his colleagues – Christoph Lüdi, Head of Systems Engineering, Alex Perrier, Senior Technology Manager, and Marco Drüssel, Mechanical Engineering Manager – have all been a part of Sensile Medical for the past ten years, and here reflect on the company’s past and discuss the future.
INTERVIEW
Arnaud Guillet
Biocorp
ARNAUD GUILLET, BIOCORP
Arnaud Guillet discusses Biocorp’s existing connected devices, value for pharmaceutical partners, accompanying software and data architecture and Biocorp's triple expertise in medical devices, electronics and software.
INTERVIEW
Tony Bratt
Nordic Group
TONY BRATT, NORDIC PHARMA
Tony Bratt discusses Nordic Pharma’s specialised market focused business model and how he believes drug delivery systems, in particular the platform device concept, can play an important role in this niche product field.
INTERVIEW
Dimitri Grasswill
Nemera
DIMITRI GRASSWILL, NEMERA
Dimitri Grasswill speaks with ONdrugDelivery Magazine, in the context of the changing market and technology around inhalation devices.
INTERVIEW
Bill Welch
Phillips-Medisize
BILL WELCH, PHILIPS-MEDISIZE
Mr Welch gives ONdrugDelivery Magazine an exclusive preview of Phillips-Medisize’s forthcoming workshop, “Realizing the Benefits of Connected Health in Respiratory Drug Delivery”.
INTERVIEW
Mathias Romacker
MATHIAS ROMACKER, PFIZER
Mathias Romacker shares his thoughts on the emergence of connectivity in drug delivery devices, he explains why he thinks the buzz around connectivity in delivery systems is more than just hype and describes the trends in the pharma sector that mean it makes sense now to connect up devices.
INTERVIEW
Simon Michel
Ypsomed
SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED
Simon Michel talks about his vision for how the connected world of drug delivery devices will evolve, and Ypsomed’s central role within it.
INTERVIEW
John Merhige
Credence MedSystems
JOHN A. MERHIGE, CREDENCE MEDSYSTEMS
John Merhige speaks about Credence’s history, people and devices, and what the company’s core philosophy, “Innovation Without Change” is really about, and how much it genuinely means to Credence.
INTERVIEW
Mike Hooven
Enable Injections
GETTING TO KNOW ENABLE INJECTIONS
Here follow five mini-interviews with key Enable members. We asked each of them the same five questions, and their answers give interesting insights, from varied perspectives, into what really makes Enable Injections tic.
INTERVIEW
Dr Elizabeth Shen
Colorcon
DR ELIZABETH SHEN, COLORCON
Elizabeth Shen talks taste-masking, from the positive impact on medication adherence, to technical approaches and technology selection, and regulatory considerations.
1
2
Next
Top
This website uses functional cookies (but not advertising cookies). View our
Privacy Policy
.
Close
Privacy & Cookies Policy
Close
Necessary
Always Enabled